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Abstract: Syntaxins are major components of
vesicle trafficking and their pattern of expression
depends on the cell type. Using reverse transcrip-
tase-polymerase chain reaction (RT-PCR), cloning,
and sequencing techniques, we have found that
human neutrophils and neutrophil-differentiated
HL-60 cells co-express syntaxins 1A, 3, 4, 5, 6, 7,
9, 11, and 16. These genes are also expressed in
human peripheral blood lymphocytes and SH-
SY5Y neuroblastoma cells, which, unlike neutro-
phils, also expressed syntaxin 10. We have identi-
fied two isoforms of syntaxin 3. Syntaxin 3A,
similar to the previously reported syntaxin 3, and
the novel isoform syntaxin 3B, which is identical to
syntaxin 3A but lacks 37 amino acid residues at the
carboxy-terminal region. Syntaxin 1 was mainly
located to neutrophil granule membranes by confo-
cal microscopy and by immunoblotting of subcellu-
lar fractions. These data indicate that syntaxin 1
cannot be considered specific to neural tissues. The
level of expression of syntaxins 3, 4, 6, and 11 was
increased during neutrophil differentiation of HL-60
cells, whereas that of syntaxins 1A, 5, 9, and 16
was unchanged. Syntaxin 7 was not expressed in
undifferentiated HL-60 cells, but its expression was
induced on neutrophil differentiation. The expres-
sion of several syntaxin genes in human neutrophils
could be related to the high secretory capacity of
these cells as well as to the presence of different
cytoplasmic granules with distinct exocytic capabili-
ties. J. Leukoc. Biol. 65: 397–406; 1999.
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INTRODUCTION
Human neutrophils constitute the first line of defense against
infection and play a major role in inflammation. Exocytosis of
the distinct granules present in human neutrophils plays a
critical role in neutrophil biology and seems to regulate a
number of important functions of these cells in both inflamma-
tion and infection, such as adhesion, extravasation, generation
of reactive oxygen metabolites, and release of lytic enzymes.
Furthermore, certain cytoplasmic granules constitute a reser-
voir of plasma membrane proteins that are mobilized to the cell
surface on cell activation [1–5]. These mobilizable granules,
named specific or secondary granules and gelatinase-contain-
ing tertiary granules, are readily exocytosed on neutrophil
activation, whereas azurophilic granules are hardly mobilized
[1, 6–8]. However, little is known about the underlying
mechanisms that regulate the exocytic process in these cells.
In contrast, a great number of proteins have been identified
in the neuronal tissue involved in the docking and fusion of
synaptic vesicles with the plasma membrane [9–11]. This has
led to the postulation of the SNARE hypothesis [9–11], which
constitutes an attractive model for vesicle-membrane fusion in
eukaryotic cells. According to the SNARE hypothesis, docking
and fusion of vesicles with the plasma membrane seems to be
modulated by the specific interaction of vesicle proteins
(v-SNAREs) with target plasma membrane-located proteins
(t-SNAREs). Both v- and t-SNAREs seem to be required on
opposing membranes for membrane fusion [12, 13]. The
prototype of v-SNARE is the synaptic vesicle membrane
protein synaptobrevin, also named vesicle-associated mem-
brane protein (VAMP). The prototypes of t-SNAREs are syn-
taxin and the 25-kDa synaptosome-associated protein (SNAP-
25). SNAP-25 is mainly detected in neuronal tissues [14], but
its presence in non-neuronal cells has also been recently
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reported [15, 16]. Another recently reported protein named
SNAP-23 [17], showing two isoforms A and B [18], seems to
fulfill the role of SNAP-25 in non-neuronal mammalian cells.
Syntaxins constitute a family of receptors for transport vesicles
[19], and it has been suggested that each target membrane may
be identified by a specific member of the syntaxin family [19].
Seven syntaxins have been previously identified and character-
ized, namely 1A, 1B, 2, 3, 4, 5, and 6 [19, 20]. Syntaxins are
255- to 301-amino acid-long proteins that contain a-helical
coiled-coil regions, likely to be involved in protein-protein
interactions, and also a region of highly hydrophobic amino
acids at the extreme carboxyl terminus, which can serve as a
membrane anchor. The fact that syntaxins 1A and 1B are only
present in the nervous system and related tissues, as well as the
diverse syntaxin distribution in distinct tissues [19–22], sug-
gests that each cell type expresses a different set of syntaxins,
and this could reflect peculiarities in cell-specific vesicle-
membrane fusion processes. In addition, the existence of 10
new syntaxins has been postulated, numbered consecutively
from syntaxin 7 to syntaxin 16, by sequence homology between
well-known syntaxins and partial DNA sequences from EST
database searches [23]. Some of these postulated new syntaxins
have been cloned very recently, such as syntaxin 7 [24, 25],
syntaxin 10 [26], syntaxin 11 [27], syntaxin 13 [28], and
syntaxin 16 [29].
In this study we have demonstrated, using a PCR-based
cloning and sequencing approach, that human neutrophils as
well as neutrophil-differentiated HL-60 cells express a wide
number of syntaxins, namely syntaxins 1A, 3, 4, 5, 6, 7, 9, 11,
and 16. We have also identified and cloned two isoforms of
syntaxin 3, namely syntaxin 3A (previous syntaxin 3) and the
novel isoform syntaxin 3B. Furthermore, the presence of
syntaxin 1 in human neutrophils was further assessed by
immunoblotting and confocal microscopy studies using the
monoclonal antibody HPC-1, able to recognize the distinct
isoforms of syntaxin 1 [30, 31]. Thus, both cloning and
immunological analyses demonstrate the expression of syntaxin
1 in human neutrophils, and thereby indicate that expression of
syntaxin 1 is not exclusive of neural tissues.
MATERIALS AND METHODS
Cell culture and leukocyte isolation
The human promyelocytic leukemia HL-60 cell line was grown in RPMI-1640
medium supplemented with 10% (v/v) heat-inactivated fetal calf serum, 2 mM
glutamine, 100 units/mL penicillin, and 24 µg/mL gentamicin at 37°C in a
humidified atmosphere of air/CO2 (19/1). Neutrophil differentiation of HL-60
cells was induced by adding 1.3% (v/v) dimethyl sulfoxide (DMSO) for the
times indicated in the respective figure as previously described [32]. The
human neuroblastoma SH-SY5Y cell line was grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% (v/v) heat-inactivated fetal
calf serum, 2 mM glutamine, 100 units/mL penicillin, and 24 µg/mL gentamicin
at 37°C in a humidified atmosphere of air/CO2 (19/1).
Neutrophils were obtained from fresh human peripheral blood by dextran
sedimentation and centrifugation on Ficoll-Hypaque (Pharmacia LKB Biotech-
nology, Uppsala, Sweden), followed by hypotonic lysis of residual erythrocytes
as previously described [33]. The gradient centrifugation was repeated once
more and the final cell preparation contained more than 99% neutrophils as
assessed by Wright-Giemsa staining. Cell viability was evaluated by trypan
blue dye exclusion and was always higher than 98%. Isolation of peripheral
blood lymphocytes was performed as previously described [34]. The band
corresponding to mononuclear cells, obtained after Ficoll-Hypaque centrifuga-
tion, was washed twice with phosphate-buffered saline (PBS) and the cell
suspension was added to Petri dishes to allow cells to adhere. Monocytes were
depleted by culture dish adherence. After overnight incubation at 37°C, the
nonadherent cells (lymphocytes) were washed with PBS and collected.
Lymphocyte preparations were typically 67–73% CD31, 25–28% CD191, and
,0.4% CD141.
Subcellular fractionation
Soluble and membrane fractions from resting human neutrophils were prepared
as previously described [16]. Neutrophils were resuspended in 50 mM
Tris-HCl, pH 7.5, containing 2 mM phenylmethylsulfonyl fluoride (PMSF), and
then disrupted by freeze-thaw. Homogenate was centrifuged at 1200 rpm
(Sorvall T 6000D) for 10 min and the supernatant, representing the postnuclear
extract (E), was saved. Total membranes were prepared by centrifugation of the
postnuclear extract at 45,000 rpm in a TLA rotor (Optima TL Ultracentrifuge,
Beckman Instruments, Palo Alto, CA) for 90 min at 4°C. Pellets were
resuspended in 50 mM Tris-HCl, pH 7.5, containing 2 mM PMSF. To prepare
subcellular fractions, resting neutrophils (about 5 3 108 cells) were fraction-
ated by rate zonal sedimentation in sucrose gradients as previously described
[35, 36]. Then, fractions enriched in cytosol, plasma membrane, and cytoplas-
mic granules, assessed by using specific marker proteins [35, 36], were saved.
The cytoplasmic granule fraction was a combination of the different granule
fractions obtained after the sucrose gradient centrifugation and contained
altogether the distinct types of intracellular granules present in neutrophils
without resolving each other. Membranes from subcellular fractions enriched in
plasma membrane and in cytoplasmic granules were obtained by diluting the
corresponding subcellular fractions with 50 mM Tris-HCl, pH 8.0, 100 mM
NaCl, and centrifugation in a 30-type rotor (Beckman Instruments) at 29,000
rpm for 90 min at 4°C as previously described [35, 36]. Then membrane pellets
were resuspended in 50 mM Tris-HCl, pH 7.5, containing 2 mM PMSF.
Western blot analysis
Proteins were separated through sodium dodecyl sulfate (SDS)-15% polyacryl-
amide gels under reducing conditions, transferred to nitrocellulose filters, and
subjected to immunological detection as previously described [16, 37]. After
blocking for 3 h at room temperature in 2% (w/v) powdered defatted milk in
Tris-buffered saline (TBS) buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl),
blots were incubated overnight with HPC-1 monoclonal anti-syntaxin 1
antibody (Sigma Chemical, St. Louis, MO; and kindly provided by Dr. Juan
Blasi, Barcelona, Spain) at a dilution of 1:2000 in TBS buffer containing 0.05%
Tween 20. Antibody reactivity was monitored with biotinylated anti-mouse IgG
(diluted 1:1000 in TBS buffer), followed by streptavidin-horseradish peroxidase
conjugate (diluted 1:1000 in TBS buffer), with the use of an enhanced
chemiluminescent detection system (Amersham, Buckinghamshire, UK).
Confocal laser scanning microscopy
Confocal microscopy was performed essentially as previously described [8].
Resting cells were resuspended (107 cells/mL) in HEPES/glucose buffer (150
mM NaCl, 5 mM KCl, 10 mM HEPES, 1.2 mM MgCl2, 1.3 mM CaCl2, 5.5 mM
glucose, pH 7.5); an aliquot (40 µL) of the cell suspension was placed on slides
and incubated at 37°C for 5 min. Cells were washed with PHEM buffer (60 mM
PIPES, 25 mM HEPES, 10 mM EGTA, 3 mM MgCl2, pH 7), and fixed in 4%
paraformaldehyde in PHEM for 10 min. After extensive washing with PBS
containing 0.1 M glycine, cells were permeabilized for 5 min with 220°C
acetone, and then washed again with PBS. Cells were blocked with 5% normal
goat serum, 5% fetal calf serum, and 1% bovine serum albumin in PBS for 1 h
at room temperature. Incubation with HPC-1 anti-syntaxin 1 monoclonal
antibody (diluted 1:1000 in PBS containing 1% bovine serum albumin) was for
1 h at 37°C in a humidified chamber. After washing with PBS, cells were
incubated with fluorescein isothiocyanate-conjugated anti-mouse antibody
(diluted 1:200 in PBS containing 1% bovine serum albumin) for 45 min in a
humidified chamber at room temperature in the dark. Slides were then washed
extensively with PBS and mounted in the aqueous medium Crystal/Mount
(BIOMEDA Corp., Foster City, CA). Negative controls were routinely prepared
by omitting the primary antibody or by using an irrelevant antibody, showing no
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fluorescence staining of the samples. Fluorescence was visualized with a ZEISS
LSM 310 laser scan confocal microscope.
RT-PCR
Total RNA was extracted and purified from the different cell types used in this
work according to the protocol of Chomczynski and Sacchi [38] or using the
Trizol reagent (GIBCO-BRL, Grand Island, NY) following the manufacturer’s
instructions. RNA preparations were carefully checked by gel electrophoresis
and found to be free of DNA contamination. Total RNA (5 µg), primed with
oligo-dT, was reverse-transcribed into cDNA with 30 units of AMV reverse
transcriptase from Promega (Madison, WI) according to the manufacturer’s
instructions in a final volume of 20 µL. The mixture was incubated at 37°C for 2
h and stored at 220°C until use. The PCR mixture (50 µL) contained the
template cDNA (1–2 µL), 20 pmol of the corresponding primers, 0.2 mM
dNTPs, 1.5–2.5 mM MgCl2, and 5 units of EcoTaq DNA polymerase derived
from Thermus aquaticus (ECOGEN, Barcelona, Spain). PCR reactions were
performed in a GeneAmp PCR System model 9600 (Perkin-Elmer, Norwalk,
CT). The primers used are listed in Table 1, where the nucleotide numbers
indicate the primer location in the corresponding sequences of human or rat
origin obtained from the GenBank/EMBL database.
Primers were designed with the PCgene programs for DNA analysis from
Intelligenetics (Mountain View, CA). The conditions for PCR amplification of
cDNA prepared from the different cell types were as follows: one cycle at 95°C
for 5 min as an initial denaturation step, then denaturation at 95°C for 30 s,
annealing for 30 s, and extension at 72°C for 90 s (30–35 cycles), followed by
further incubation for 15 min at 72°C (one cycle). The annealing step was
carried out at 50°C (syntaxin 7 and syntaxin 16), 55°C (syntaxin 1A, syntaxin 4,
syntaxin 9, and syntaxin 10), 57°C (syntaxin 3 and syntaxin 11), 62°C (syntaxin
6), 65°C (syntaxin 2), and 69°C (syntaxin 5 and syntaxin 13).
In the case of HL-60 cells, we also used a semiquantitative RT-PCR analysis
to assess mRNA expression as previously described [39] and using the b-actin
gene (GenBank/EMBL accession number: X00351) as an internal control. The
sense and anti-sense primers for b-actin cDNA amplification were 58-
CTGTCTGGCGGCACCACCAT-38 and 58-GCAACTAAGTCATAGTCCGC-38.
This primer pair amplifies a 254-bp fragment (nucleotides: 936–1189). For the
RT reaction, total RNA (5 µg) from untreated and DMSO-treated HL-60 cells
was primed with oligo-dT and reverse-transcribed into cDNA with 30 units of
AMV RT (Promega) in a 20-µL volume. A 50-µL PCR mixture contained 2 µL of
the RT reaction and the reagents used were as described above. The PCR
conditions, to analyze syntaxin gene expression during neutrophil differentia-
tion of HL-60 cells, were the same as above except for the following changes for
annealing temperature, Mg21 concentration, and number of cycles: syntaxin 1A
(55°C, 1.5 mM Mg21, 29 cycles), syntaxin 3 (60°C, 1.5 mM Mg21, 27 cycles),
syntaxin 4 (60°C, 1.5 mM Mg21, 27 cycles), syntaxin 5 (69°C, 1.5 mM Mg21, 27
cycles), syntaxin 6 (62°C, 1.5 mM Mg21, 27 cycles), syntaxin 7 (57°C, 1.5 mM
Mg21, 27 cycles), syntaxin 9 (69°C, 1.5 mM Mg21, 26 cycles), syntaxin 11
(69°C, 1 mM Mg21, 27 cycles), syntaxin 16 (66°C, 1.5 mM Mg21, 27 cycles),
b-actin (60°C, 1.5 mM Mg21, 24 cycles). These experimental conditions were
shown to be at the linear phase of amplification for each gene. An aliquot of the PCR
reaction was analyzed on a 2% agarose gel (syntaxins 1A, 3, 4, 5, 6, and 13) or 3%
agarose gel (syntaxins 7, 9, 10, 11, and 16) in 1 3 TAE (40 mM Tris-acetate,
1 mM EDTA, pH 8.0), and checked for the expected PCR products.
cDNA cloning and sequencing
The PCR products were directly cloned into the pCRy2.1 vector using the TA
cloning kit (Invitrogen, San Diego, CA) following the manufacturer’s instruc-
tions. DNA sequencing was performed by thermal cycle sequencing using
Cy5yAutoCycley sequencing kit (Pharmacia) and by automated laser fluores-
cent DNA sequencing (Pharmacia) as well as using a PE Applied Biosystems
377 DNA Sequencer (Perkin-Elmer). DNA sequencing was performed on both
strands from at least 10 independent cDNA clones for each gene.
RESULTS
Syntaxin expression in human neutrophils
We have used RT-PCR to analyze the expression of the distinct
syntaxins in human neutrophils, using appropriate sets of
primers for the corresponding human (syntaxins 1A, 3, 4, and 5)
and rat (syntaxins 2 and 6) genes. Two isoforms of syntaxin 1,
named syntaxin 1A and syntaxin 1B, specific for neuronal
tissues have been identified in rat [19, 22, 31]. They share 84%
amino acid identity. Syntaxin 1A from human brain has also
been cloned and sequenced [40]. This human syntaxin 1A
shows a 98% amino acid sequence identity with the rat syntaxin
1A homolog [40]. Thus, we used primers for human syntaxin 1A
to examine expression of syntaxin 1 in human neutrophils. We
found expression of syntaxins 1A, 3, 4, 5, and 6, as assessed by
detection of the appropriate PCR bands with the expected sizes
for the syntaxins 1A, 3, 4, 5, and 6 amplified fragments (Fig.
1A), and by subsequent cloning and sequencing of these
amplified fragments (data not shown). In the case of syntaxin 4,
we detected two amplified PCR fragments (Fig. 1A), correspond-
TABLE 1.
syntaxin 1A (accession number: L37792)
(forward; nt 133–152): 58-TGACAAGATCGCAGAGAACG-38
(reverse; nt 593–612): 58-TTGATGATCTCACTGTGCCG-38
syntaxin 2A (accession number: L20823)
(forward; nt 77–99): 58-AGAAGGACCACTTCATGGATGCC-38
(reverse; nt 860–879): 58-ACGCAATCATTTGCCAACCG-38
syntaxin 3 (accession number: U32315)
set 1
(forward; nt 221–244): 58-GATCTCAGAACATGTAGAGGAGGC-38
(reverse; nt 924–944): 58-ATTCAGCCCAACGGAAAGTCC-38
set 2
(forward; nt 221–244): 58-GATCTCAGAACATGTAGAGGAGGC-38
(reverse; nt 924–947): 58-TTAATTCAGCCCAACGGAAAGTCC-38
set 3
(forward; nt 78–101): 58-ATGAAGGACCGTCTGGAGCAGCTG-38
(reverse; nt 924–947): 58-TTAATTCAGCCCAACGGAAAGTCC-38
syntaxin 4 (accession number: X85784)
set 1
(forward; nt 1–20): 58-ATGCGCGACAGGACCCACGA-38
(reverse; nt 477–496): 58-CAGCATTGGTGATCTTCAGC-38
set 2
(forward; nt 128–146): 58-ACAAGGTCCGGACAATTCG-38
(reverse; nt 872–894): 58-TTATCCAACCACTGTGACGCCAA-38
set 3
(forward; nt 128–146): 58-ACAAGGTCCGGACAATTCG-38
(reverse; nt 477–496): 58-CAGCATTGGTGATCTTCAGC-38
syntaxin 5 (accession number: U26648)
(forward; nt 107–130); 58-TAAGCCAGCTTTGCGTGCTGTCCG-38
(reverse; nt 812–835): 58-TTGAGGATCTCTGAATGGGCGGCC-38
syntaxin 6 (accession number: U56815)
(forward; nt 206–230): 58-TGCCCAGGGATTGTTCCAGAGATGG-38
(reverse; nt 856–880): 58-AGGACCGCGAAGAGGATGGCTATGG-38
syntaxin 7 (accession number: D60600)
(forward; nt 147–169): 58-TCAACCATGTCTTACACTCCAGG-38
(reverse; nt 335–359): 58-GTACTTATCTGTTTCTTTGGCAAGC-38
syntaxin 9 (accession number: AA150357)
(forward; nt 9–32): 58-GAACAGGAAGCAAAGTACCAGGCC-38
(reverse; nt 333–357): 58-TTCATCACAATAGAGTGGAAATCCG-38
syntaxin 10 (accession number: W24393)
(forward; nt 64–88): 58-GTTGGAGAAGAGCTGGACGAGCAGG-38
(reverse; nt 315–339): 58-AAGATGAGAACGAGGAGAAGCACCC-38
syntaxin 11 (accession number: AA227632)
(forward; nt 157–176): 58-TTTGGTGCGTCCTTCCCAGC-38
(reverse; nt 386–406): 58-TCTTCTTGCAGATGGCGGTGC-38
syntaxin 13 (accession number: AA167677)
(forward; nt 21–45): 58-GCTCCTCGTCATGTCATACGGTCCC-38
(reverse; nt 581–602): 58-TCAGCTCAACTGCCGAATGCCG-38
syntaxin 16 (accession number: AA100145)
(forward; nt 43–64): 58-GGGCGATGATTGTAGAACAGGG-38
(reverse; nt 234–255): 58-TGCCACTTATCGAGACTTCACG-38
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ing the lower band to the previously sequenced syntaxin 4 [15].
We failed to detect expression of syntaxin 2 under the
experimental conditions used. However, this lack of syntaxin 2
detection could be due to the rat origin of the primers used.
The existence of several new syntaxins has been postulated
by Bock and Scheller [23], ranging from syntaxin 7 to syntaxin
16, based on the homology between well-characterized syntax-
ins and several related EST sequences. Some of these postu-
lated new syntaxins, derived from DNA partial sequences of
EST databases, are of human origin (syntaxins 7, 9, 10, 11, 12,
13, 14, and 16), but others are of mouse origin (syntaxins 8 and
15). Thus, we designed primers for the EST sequences corre-
sponding to the postulated syntaxins 7, 9, 10, 11, 13, and 16
derived from human EST sequences, and analyzed the expres-
sion of these new syntaxins in human neutrophils by RT-PCR.
The sequences available in the EST database for both syntaxins
12 and 14 were very short, not suitable for primer design and
subsequent analysis of the respective amplified fragments,
precluding their appropriate detection by RT-PCR. As shown in
Figure 1B, we detected bands with the expected sizes for the
amplified fragments of syntaxins 7, 9, 11, and 16, which were
then cloned and sequenced. Analysis of the cloned nucleotide
sequences (data not shown) revealed that these PCR fragments
corresponded to syntaxins 7, 9, 11, and 16. However, we were
not able to detect any amplified fragment with the expected size
for syntaxins 10 and 13 under the experimental conditions
used. These results indicate that human neutrophils express the
postulated new syntaxins 7, 9, 11, and 16.
Cloning of two isoforms of syntaxin 3 and of a
syntaxin 4 precursor
We used different sets of PCR primers with wide overlapping
regions designed from the corresponding genes (see Materials
and Methods) in order to sequence the complete encoding
regions of syntaxins 3 and 4. Following this approach, we have
cloned and sequenced two variant isoforms of syntaxin 3,
termed syntaxin 3A and syntaxin 3B (Fig. 2). The complete
nucleotide sequence of syntaxin 3A contained an open reading
frame of 870 nucleotides coding for a protein composed of 289
amino acids with a deduced molecular mass of about 33.2 kDa.
Syntaxin 3A from human neutrophils showed a strong homology
with that of rat origin previously reported [19], with 75
differences in nucleotide sequence (91.4% identity) and only
six changes in the amino acid sequence (97.9% identity; Fig.
2). In addition, using the set 2 of primers for syntaxin 3
(Materials and Methods), we were able to clone and partially
sequence a novel syntaxin 3 isoform, termed syntaxin 3B,
which shows a total identity to syntaxin 3A between the
nucleotides 145–675 and 787–870, and a gap between the
nucleotides 676–786 of the syntaxin 3A coding sequence.
Thus, syntaxin 3B is identical to syntaxin 3A but lacks 37
amino acid residues, from amino acid 226 to amino acid 262
(Fig. 2). Syntaxin 3A has one potential target sequence of
phosphorylation by cAMP/cGMP-dependent protein kinase in
Thr-161 and four potential sites of phosphorylation by protein
kinase C at the residues Ser-124, Thr-156, Ser-207, and
Thr-250, this last one being absent in syntaxin 3B. The syntaxin
3A protein also contains two potential amino-myristoylation
sites at Gly residues 180 and 283, which are preserved in
syntaxin 3B, as well as an epimorphin family signature between
amino acid residues 197–235. Mouse syntaxin 3 has been
reported to show four different isoforms with differences either
in the carboxyl- or the amino-terminal region [41] but the novel
human syntaxin 3B described here (Fig. 2) does not correspond
to any of the previously reported mouse syntaxin 3 isoforms.
The two-band PCR pattern obtained for syntaxin 4 (Fig. 1A)
was always observed using the three different pairs of primers
described in Materials and Methods (Fig. 1, A and C). The
upper and lower amplified fragments, obtained from sets 1 and
2 of primers for syntaxin 4 (see Materials and Methods) shown
in Figure 1C, were cloned in the pCR2.1 vector using the TA
cloning system and sequenced. The sequence of the lower band
corresponded exactly to the previously reported sequence for
human syntaxin 4 from skeletal muscle [15]. The sequence of
the upper band corresponded to that of syntaxin 4, but
contained an insertion of 136 nucleotides (Fig. 3). This insert
had several stop codons and contained the highly conserved
sequences for RNA splicing in higher eukaryotes, namely GT at
the 58 splice site (donor site) and AG at the 38 splice site
(acceptor site; Fig. 3), which are required for intron removal.
The complete sequence of the larger band rendered a complete
sequence of 1030 nucleotides showing an intron sequence of
Fig. 1. PCR of cDNAs from human neutrophils using primers for several syntaxins. Total RNA was extracted from resting cells, reverse-transcribed into cDNA, and
followed by amplification by cycle repeating denaturation, annealing, and primer extension as described in Materials and Methods. Primer sequences and conditions
for cDNA amplification are detailed in Materials and Methods. (A) PCR products of cDNA amplification using specific primers for syntaxin 1A, syntaxin 3, syntaxin
4, syntaxin 5, and syntaxin 6. The sets of primers 1 and 3, detailed in Materials and Methods, were used for RT-PCR amplification of syntaxins 3 and 4, respectively.
(B) PCR products of cDNA amplification using specific primers for syntaxin 7, syntaxin 9, syntaxin 11, and syntaxin 16. (C) PCR products of cDNA amplifications
using the sets of primers 1 and 2 for syntaxin 4 detailed in Materials and Methods. Standards (wX174 DNA digested with HaeIII) were run at both sides of each gel.
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136 nucleotides between the coding regions 1–232 and 369–
1030.
Syntaxin expression in neutrophil-differentiated
HL-60 cells
To further assess the presence of the above-described syntaxins
in human neutrophils, we examined the expression of these
neutrophil-expressed syntaxins in the human promyelocytic
HL-60 cell line. This is a homogeneous human cell line that
can be differentiated toward the neutrophil lineage and it is
used as a cell culture model to study neutrophil biology [32].
We found that the pattern of expression of syntaxin genes shown
in peripheral blood mature neutrophils (Fig. 1) was identical to
that found in DMSO-differentiated HL-60 cells (Fig. 4), which
were used as a cell culture model for neutrophils [32]. It has
been previously shown that treatment of HL-60 cells with
DMSO for 4 days leads to their differentiation toward cells
displaying many neutrophil functions and characteristics [32].
As shown in Figure 4, all the syntaxin genes expressed in
human neutrophils were also detected by RT-PCR in neutrophil-
differentiated HL-60 cells (see Figs. 1 and 4). The identifica-
tion of each syntaxin was further assessed by cloning and
subsequent sequencing of each amplified fragment. Cloning
and sequencing of these syntaxin genes (syntaxins 1A, 3A, 3B,
4, 5, 6, 7, 9, 11, and 16) expressed in neutrophil-differentiated
HL-60 cells revealed the same sequences as their correspond-
ing counterparts from peripheral blood neutrophils, further
confirming their expression in human neutrophils. In addition,
following the same approach as that used in peripheral blood
human neutrophils, we also cloned and sequenced the above-
described syntaxin 3B as well as the syntaxin 4 precursor in
neutrophil-differentiated HL-60 cells.
We also determined the level of expression of different
syntaxins during DMSO-induced differentiation of the human
promyelocytic leukemia HL-60 cell line toward the neutrophil
lineage by semiquantitative RT-PCR. This RT-PCR analysis
revealed the presence of relatively high levels of syntaxins 3, 4,
5, 9, and 16, as well as lower levels of syntaxins 1A, 6, and 11
in undifferentiated HL-60 cells (Fig. 4). Syntaxin 7 was not
expressed in undifferentiated HL-60 cells (Fig. 4). The level of
expression of syntaxin 6 was highly increased after 1-day
treatment of HL-60 cells with DMSO (Fig. 4), the time required
to commit HL-60 cells toward the neutrophil lineage [42].
Syntaxin 7 was expressed after a 2-day treatment of HL-60 cells
with DMSO (Fig. 4). These data indicate that the expression of
syntaxin 7 is under a tight regulatory control during neutrophil
differentiation. Also, the expression of syntaxins 3, 4, and 11
was increased during neutrophil differentiation, whereas the
level of expression of syntaxins 1A, 5, 9, and 16 was not
modified along the DMSO-induced differentiation process of
HL-60 cells (Fig. 4). It is interesting to note that the precursor
form of syntaxin 4 observed in human neutrophils (Figs. 1 and
3) was not detected in undifferentiated HL-60 cells, but was
accumulated after DMSO treatment (Fig. 4). This result corrobo-
Fig. 2. Amino acid sequences of syntaxin 3A and syntaxin 3B from human neutrophils, and homology with rat syntaxin 3. The complete amino acid sequence of
human syntaxin 3A (Hum-SYNT3A) is compared with the partial amino acid sequence of human syntaxin 3B (Hum-SYNT3B), showing the lack of 37 amino acids
between residues 226–262. The deduced amino acid sequences of syntaxins 3A and 3B were aligned with that of rat syntaxin 3 (Rat-SYNT3). The bold amino acid
residues indicate differences between human and rat amino acid sequences.
Martı´n-Martı´n et al. Syntaxin expression in neutrophils and HL-60 cells 401
rates that obtained from human neutrophils and suggests that a
regulatory mechanism at the level of RNA splicing could
constitute a rate-limiting step in the modulation of the levels of
syntaxin 4 during neutrophil development.
Comparative expression of syntaxins in
neutrophils, lymphocytes, and SH-SY5Y
neuroblastoma cells
We have compared the patterns of expression of syntaxins in
human neutrophils, lymphocytes, and SH-SY5Y neuroblastoma
cells using the same experimental conditions described in
Materials and Methods for all the cell types (Fig. 5). Because
the number of cycles used in these studies was higher than that
used in Figure 4, we have also included the data obtained from
undifferentiated and neutrophil-differentiated HL-60 cells, to
further examine the expression of some syntaxins that are either
weakly or scarcely expressed (syntaxins 3B, 6, and 7) in
undifferentiated HL-60 cells when semiquantitative RT-PCR
conditions were used (Fig. 4). Syntaxin 2 has not yet been
cloned in human tissues and we were unable to detect any
amplification PCR product of the expected size for syntaxin 2
using the primers of rat origin. We also failed to detect
expression of syntaxin 13 under the experimental conditions
used. However, this lack of expression in the cell types tested,
together with the rat origin of the syntaxin 2 primers, does not
permit us to conclude whether these two syntaxins are ex-
pressed in neutrophils. As shown in Figure 5, we have shown
that SH-SY5Y neuroblastoma cells express, in general, higher
levels of syntaxins than neutrophils. Human peripheral blood
lymphocytes also express all the syntaxins found in human
neutrophils. In addition, both SH-SY5Y cells and lymphocytes
express significant levels of syntaxin 10, which is not detected
in human neutrophils (Fig. 5). Syntaxins 1A and 4 are
expressed in neutrophils at much lower levels than in the other
cell types assayed (Fig. 5). The two-band PCR pattern for
syntaxin 4 was also observed in lymphocytes and SH-SY5Y
cells (Fig. 5), even though the relative proportion of the syntaxin
4 precursor (upper band) compared to the fully processed
syntaxin 4 (lower band) seems to be higher in human neutro-
phils, and is very low in SH-SY5Y cells. We have also been able
to detect a two-band PCR pattern for syntaxin 3 in undifferenti-
ated and differentiated HL-60 as well as in SH-SY5Y cells (Fig.
5). This lower band of the two-band pattern for syntaxin 3 was
also present but hardly visible in gel, in human neutrophils, due
to its much lower content in this cell type (Fig. 5). Cloning and
sequencing analyses indicated that these two bands corre-
sponded to the above-mentioned syntaxin 3A (upper band) and
syntaxin 3B (lower band; Fig. 2). The data shown in Figure 5
indicate that syntaxin 3B is expressed at a much lower level
than syntaxin 3A in the different cell types assayed (Fig. 5).
Under the experimental conditions used in Figure 5, we could
observe detectable levels of syntaxin 6 expression in undifferen-
tiated HL-60 cells that were increased on DMSO treatment,
whereas no expression of syntaxin 7 was detected in undifferen-
tiated HL-60 cells. These results further indicate that untreated
HL-60 cells do not express syntaxin 7 and that its expression is
induced during HL-60 differentiation toward neutrophils.
Fig. 3. Nucleotide sequence of human neutrophil syntaxin 4 containing an intron sequence. Partial sequences of the DNA strands corresponding to the mature
mRNA (SYNTAXIN4) and to the mRNA precursor (PRECURSOR) sequences of syntaxin 4 from human neutrophils are shown. The mRNA precursor of syntaxin 4
contains an intron sequence of 136 nucleotides as indicated. The highly conserved GT and AG nucleotides at the beginning and at the end of the intron are
underlined and shown in bold.
402 Journal of Leukocyte Biology Volume 65, March 1999 http://www.jleukbio.org
Identification and intracellular localization
of syntaxin 1 in human neutrophils
As shown in Figures 1A, 4, and 5, we detected an amplified
PCR product, with the expected size, in human neutrophils and
HL-60 cells using specific primers for syntaxin 1A. After
subsequent cloning and sequencing of this PCR amplified
product, we found that this PCR band corresponded to syntaxin
1A. These results indicate that syntaxin 1, particularly syntaxin
1A, previously thought to be specific for neuronal tissues [19,
22, 31], is expressed in human neutrophils and HL-60 cells. In
addition, we found that syntaxin 1A was also expressed in
human peripheral blood lymphocytes and in the SH-SY5Y
neuroblastoma cell line (Fig. 5).
The presence of syntaxin 1 in human neutrophils was further
assessed by immunoblotting and confocal microscopy tech-
niques. To examine the presence of syntaxin 1 in human
neutrophils, we carried out immunoblotting analysis from
neutrophil extracts as well as from cytosol and membrane
fractions. We used the monoclonal antibody HPC-1 against
syntaxin 1A/1B, which has been widely used to immunolocalize
syntaxin 1 [22, 30, 31, 43, 44]. This HPC-1 monoclonal
antibody recognized only an intense band, which corresponded
to a protein with an apparent molecular mass of about 35 kDa,
similar to that of syntaxin 1 (Fig. 6A). In fact, the HPC-1
monoclonal antibody recognized an identical band of about 35
kDa in homogenates of both rat brain and human neutrophils
(data not shown), which further assessed the specificity of the
immunodetected band. The protein recognized by the HPC-1
antibody in human neutrophils was membrane-bound (Fig. 6A).
Immunoblotting analysis of distinct subcellular fractions pre-
pared from resting human neutrophils indicated that this
syntaxin 1 immunoreactive protein band was mainly located in
the fraction enriched in the membranes prepared from cytoplas-
mic granules, with a minor location in plasma membrane, and
was absent from cytosol (Fig. 6B). The granule membranes were
prepared from the whole neutrophil granule population, without
resolving the distinct intracellular granules present in human
neutrophils. Immunofluorescence confocal microscopy for syn-
taxin 1, using the HPC-1 monoclonal antibody, showed a
granular pattern in resting human neutrophils (Fig. 7). This
further indicates a granule localization for this protein.
Fig. 4. Expression of human syntaxin genes during DMSO-induced differen-
tiation of HL-60 cells toward the neutrophil lineage. The expression of syntaxin
1A, syntaxin 3 (set 1 of primers), syntaxin 4 (set 3 of primers), syntaxin 5,
syntaxin 6, syntaxin 7, syntaxin 9, syntaxin 11, and syntaxin 16 was assessed by
a semiquantitative RT-PCR analysis. Total RNA was purified from untreated
HL-60 cells as well as from HL-60 cells treated with 1.3% (v/v) DMSO for the
indicated times, and subjected to semiquantitative RT-PCR analysis with
oligonucleotide primers specific for each syntaxin gene as described in
Materials and Methods. PCR amplification of b-actin was used as an internal
control. After 29 cycles (syntaxin 1A), 27 cycles (syntaxin 3, syntaxin 4,
syntaxin 5, syntaxin 6, syntaxin 7, syntaxin 11, and syntaxin 16), 26 cycles
(syntaxin 9), and 24 cycles (b-actin), shown to be at the linear phase of
amplification, the PCR products were electrophoresed onto 2 or 3% agarose
gels and stained with ethidium bromide.
Fig. 5. Expression of several human syntaxin genes in neutrophils, lympho-
cytes, and SH-SY5Y neuroblastoma cells. Total RNA was extracted from cells,
reverse-transcribed into cDNA, and followed by amplification by cycle
repeating denaturation, annealing, and primer extension as described in
Materials and Methods. Primer sequences and conditions for cDNA amplifica-
tion are detailed in Materials and Methods. The expression of some syntaxins
(syntaxins 3, 6, and 7) in undifferentiated HL-60 cells (HL-60) and in HL-60
cells treated for 4 days with DMSO (HL-601DMSO) is also included. The
number of cycles used for PCR amplification of syntaxin 3 was increased up to
40. The two-band PCR patterns obtained for syntaxin 4 and syntaxin 3
correspond to the amplification of the normal syntaxin 4 (lower band) and the
syntaxin 4 precursor described in Figures 1 and 3 (upper band), as well as to
syntaxin 3A (upper band) and syntaxin 3B (lower band).
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DISCUSSION
This study is the first report analyzing the pattern of expression
of syntaxins in human neutrophils, a non-neuronal cell type
where exocytosis of cytoplasmic granules plays a key role in its
physiology. In order to assess the neutrophil origin of the cloned
genes herein reported, we used both a highly purified human
peripheral blood neutrophil preparation and the homogeneous
human promyelocytic leukemia HL-60 cell line, which can be
differentiated toward neutrophils and is widely used as a cell
culture model for the study of different aspects of human
neutrophil biology [32, 45, 46]. HL-60 cells are committed to
differentiate toward the neutrophil lineage after 1-day DMSO
treatment [42], and are fully differentiated toward cells sharing
many mature neutrophil features after a 4-day DMSO treatment
[32]. We have found here an identical pattern of expression of
syntaxin genes in both human peripheral blood mature neutro-
phils and HL-60 cells differentiated toward neutrophils with
DMSO. From these data, we conclude that human neutrophils,
and neutrophil-differentiated HL-60 cells, express syntaxins
1A, 3A, 3B, 4, 5, and 6, as well as the postulated new syntaxins
7, 9, 11, and 16, as assessed from RT-PCR, cloning, and
sequencing analyses. Previous reports indicated that human
neutrophils contained several SNARE proteins, namely: syn-
taxin 4 [47], VAMP-2 [47], and SNAP-25 [16], based on the use
of specific antibodies; and SNAP-23 A and B [18], based on
cloning and sequencing approaches. Taking these data together,
it can be envisaged that human neutrophils contain all the
components, v-SNAREs and t-SNAREs, required by the SNARE
hypothesis. The presence of Rap1 and Rap2 proteins in human
neutrophils, putatively involved in the regulation of exocytosis,
has also been reported [37, 48]. The putative presence of
distinct combinations of these docking-fusion proteins in the
different types of cytoplasmic granules present in human
neutrophils could explain the independent mobilization of
these granules during neutrophil activation.
Syntaxin 3 was found to be expressed as two isoforms, named
3A and 3B. This novel human syntaxin 3B isoform is identical
to syntaxin 3A, but lacks 37 amino acid residues, and it is
expressed at much lower levels than syntaxin 3A. It is
interesting to note the detection by RT-PCR of a syntaxin 4
precursor in human neutrophils that results from an incomplete
RNA splicing. This syntaxin 4 precursor was accumulated on
DMSO-induced HL-60 differentiation. The accumulation of an
RNA splicing intermediate could suggest the putative existence
of a regulatory mechanism at the level of RNA splicing, acting
as a rate-limiting step in modulating the levels of syntaxin 4
during neutrophil development and in mature neutrophils. This
RNA splicing intermediate was also found in human lympho-
cytes and SH-SY5Y neuroblastoma cells. Thus, the observation
of a syntaxin 4 splicing intermediate with an intron of 136
nucleotides might reflect a limiting step in the processing of
this gene RNA, perhaps related to the large structure of the
spliceosome complex [49, 50] and the small size of this intron.
To compare neutrophil syntaxin expression with that found in
other human cell types, we examined comparatively syntaxin
expression in human neutrophils, lymphocytes, and SH-SY5Y
neuroblastoma cells. We have found that both peripheral blood
lymphocytes and SH-SY5Y cells expressed all the syntaxins
detected in human neutrophils. In addition, syntaxin 10 was
expressed in lymphocytes and neuroblastoma cells, but not in
human neutrophils. This suggests that syntaxin 10 is not
expressed in human neutrophils. A recent report showed the
presence of syntaxin 1 in SH-SY5Y neuroblastoma cells with
the use of Western blot analysis [44] but other syntaxins were
not analyzed [44]. Thus, this study constitutes the first evidence
for syntaxin expression in human lymphocytes and human
SH-SY5Y neuroblastoma cells, and demonstrates that these
cell types express syntaxins 1A, 3A, 3B, 4, 5, 6, 7, 9, 10, 11,
Fig. 6. Immunodetection and subcellular distribution of syntaxin 1 in resting
human neutrophils. (A) Membrane association of syntaxin 1. Postnuclear
extract (E) from resting human neutrophils was prepared as described in
Materials and Methods. Then the total membrane fraction (M) as well as the
soluble fraction (S), including cytosolic and soluble proteins, were obtained as
described in Materials and Methods. Proteins from postnuclear extract (60 µg),
membrane (30 µg), and soluble (60 µg) fractions were run on a SDS-15%
polyacrylamide gel and analyzed by immunoblotting using the anti-syntaxin-1
HPC-1 monoclonal antibody. (B) Granule membrane localization of syntaxin 1.
Equal amounts of cytosolic (C), plasma membrane (PM), and granule membrane
(GM) proteins (60 µg), prepared from resting human neutrophils as described in
Materials and Methods, were run on a SDS-15% polyacrylamide gel and
analyzed by immunoblotting using the anti-syntaxin-1 HPC-1 monoclonal
antibody. Molecular masses (kDa) of protein markers are indicated on the left.
Fig. 7. Localization of human syntaxin 1 in resting neutrophils by confocal
laser scanning microscopy. Cells were permeabilized and incubated with
anti-syntaxin 1 HPC-1 monoclonal antibody as described in Materials and
Methods. One cell is shown. Bar, 8 µm. Data shown are representative of three
separate experiments.
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and 16. The ubiquitous expression of these syntaxins suggests
their involvement in pathways that are common to all cell types.
However, it could be envisaged that some syntaxins may play
distinct roles in different cell types. Human neutrophils are
terminal nonproliferating cells that have a reduced capacity of
macromolecule biosynthesis [51] but manifest a prominent
secretory capacity [1, 5]. Accordingly, the cytoplasm of these
short-lived, highly specialized phagocytes is full of cytoplasmic
granules, many of them readily exocytosed on cell activation
[1, 5]. Functional and morphological changes coupled to the
conversion of proliferating cells toward terminal non-proliferat-
ing, phagocytic, and secretory cells are observed during
neutrophil maturation in bone marrow, and HL-60 neutrophil
differentiation partially mimics some of these changes [32, 45,
46]. The fact that expression of some syntaxins is increased
during HL-60 neutrophil differentiation suggests a more special-
ized role for these syntaxins. The induction of syntaxin 7 during
HL-60 differentiation toward the neutrophil lineage is of
particular interest. This syntaxin has been recently cloned [24,
25] and found to be associated with the early endosome
compartment [25]. We have found that syntaxin 7 is not
expressed in undifferentiated HL-60 cells, but its expression is
induced during the early phases of DMSO-induced HL-60
differentiation toward the neutrophil lineage. These data indi-
cate that expression of syntaxin 7 is highly regulated during
neutrophil differentiation and, thereby, suggest a putative role
for syntaxin 7 in some specialized functions of mature neutro-
phils. In addition, the low level of syntaxin 6 expression
detected in undifferentiated HL-60 cells is increased on
neutrophil differentiation. Bock et al. [20, 52] found that
syntaxin 6 is widely expressed and localizes in the region of the
Golgi apparatus. Therefore, it seems to play a role in a universal
biological process. However, it could also be speculated that
syntaxin 6 could play an additional and more specialized role in
human neutrophils because its expression is increased during
neutrophil differentiation of HL-60 cells. Similar more special-
ized roles occurring in mature neutrophils could be putatively
assigned to syntaxins 3, 4, and 11, which are also induced
during neutrophil differentiation of HL-60 cells. In this regard,
we have previously found that expression of SNAP-23 is also
increased during DMSO-induced differentiation of HL-60 cells
toward neutrophils [18].
A major finding in this report is the identification of syntaxin
1 in human neutrophils by both genetic and immunological
approaches. RT-PCR analysis, followed by cloning and sequenc-
ing, allowed identification of syntaxin 1A in human neutrophils
and HL-60 cells. This gene was also expressed in human
lymphocytes and SH-SY5Y neuroblastoma cells. Thus, the data
herein reported indicate that syntaxin 1A is not exclusive of
neuronal tissues as previously reported [19, 22, 31]. In
addition, we report evidence for the identification of syntaxin 1
in human neutrophils using the monoclonal antibody HPC-1,
which has been broadly used to immunolocalize syntaxin 1 [22,
30, 31, 43, 44]. Immunoblotting of subcellular fractions and
immunofluorescence confocal microscopy studies reveal that
syntaxin 1 is mainly located in the membranes of cytoplasmic
granules in human resting neutrophils, with a minor location in
plasma membrane. This HPC-1 monoclonal antibody is able to
recognize the previously two reported isoforms of syntaxin 1,
named 1A and 1B [30, 31]. Jagadish et al. have recently
reported a novel isoform of syntaxin 1, termed 1C, which is also
recognized by the HPC-1 monoclonal antibody [43]. Unlike
previous syntaxins 1A and 1B, which were previously reported
to be specific for neuronal tissues, syntaxin 1C is expressed in
several human tissues [43]. Syntaxins 1A and 1B consist of 288
amino acid residues, whereas syntaxin 1C contains 260 resi-
dues [43]. Due to the close molecular masses of the syntaxin 1
isoforms, it is possible that HPC-1 monoclonal antibody
recognizes other syntaxin 1 isoforms, in addition to the cloned
syntaxin 1A, in human neutrophils. The main granule localiza-
tion of syntaxin 1 in human neutrophils differs from the plasma
membrane location previously reported for this syntaxin in
neuronal tissues [19, 22, 31], consistent with its proposed role
as t-SNARE in nerve terminals [53]. Although syntaxin 1 has
normally been described as a t-SNARE, some studies report its
association with synaptic vesicles and with chromaffin granules
[21, 54, 55].
The expression of a wide number of proteins involved in
vesicle-membrane fusion processes in neutrophils could be
related to their high secretory capacity and to the presence of
distinct neutrophil cytoplasmic granules with different exocytic
capabilities. However, the roles of the distinct syntaxin family
members in human neutrophils remain to be elucidated.
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